参考文献/References:
[1]那彦群.中国泌尿外科疾病诊断治疗指南 -2007版 [M] .北京 :人民卫生出版社, 2007: 216-226.
[2] Uribarri J, Oh MS, Carroll HJ. The first kidney stone [J]. Ann Intern Med, 1989, 111(12): 1006-1009.
[3] MoeOW.Kidneystones:pathophysiologyandmedicalmanagement [J]. Lancet, 2006, 367(957): 333-344.
[4] Maalouf NM, Cameron MA, Moe OW, et al. Novel insights into the pathogenesis of uric acid nephrolithiasis[J]. Curr Opin Nephrol Hypertens, 2004, 13(2): 181-189.
[5] Monga M, Macias B, Groppo E, et al. Genetic heritability of urinary stone risk in identical twins[J]. J Urol, 175(6): 2125-2128.
[6]叶章群 .泌尿系结石研究现况与展望 [J].中华实验外科杂志, 2005, 22(3): 261-262.
[7] Khan SR. Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies[J]. Clin Exp Nephrol, 2004, 8(2): 75-88.
[8] De Water R, Noordermeer C, Houtsmuller AB, et al. Role of macrophages in nephrolithiasis in rats: an analysis of the renal interstitium[J]. Am J Kidney Dis, 2000, 36(3): 615-625.
[9]奉有才,邓耀良,陶芝伟,等.高迁移率族蛋白 B1对磷酸钙诱导巨噬细胞释放炎症因子的协同作用 [J].中国组织工程研究, 2014, 18(33): 5317-5322.
[10] Rhee E, Santiago L, Park E, et al. Urinary IL-6 is elevated in patients with urolithiasis[J]. J Urol, 160(6 Pt 1): 2284-2288.
[11] Mittal RD, Bid HK, Manchanda PK, et al. Association of interleukin-1beta gene and receptor antagonist polymorphisms with calcium oxalate urolithiasis [J]. J Endourol, 2007, 21 (12): 1565-1570.
[12] Daly C, Rollins BJ. Monocyte chemoattractant protein-1(CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies [J]. Microcirculation, 2003,10 (3-4): 247-257.
[13] Viedt C, Dechend R, Fei J, et al. MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factor-kappaB and activating protein-1[J]. J Am Soc Nephrol, 13(6): 1534-1547.
[14]岳树强,窦科峰,李开宗,等.乌司他丁和肿瘤坏死因子 α抗体对大鼠肝脏缺血再灌注损伤的保护作用 [J].中国医师杂志 , 2004, 6(1): 36-38.
[15] Donnahoo KK, Meldrum DR, Shenkar R, et al. Early renal ischemia, with or without reperfusion, activates NFκB and increases TNFα bioactivity in the kidney[J]. J Urol, 2000, 163(4): 1328-1332.
[16] Kitamoto Y, Nakamura E, Kudo S, et al. Thrombin in synovial fluid as a marker of synovial inflammation: a definite measurement by ELISA and correlation with VEGF[J]. Clin Chim Acta, 2008, 398(1/2): 159-160.
[17] Saucier NA, Sinha MK, Liang KV, et al. Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota[J]. Am J Kidney Dis, 2010, 55(1): 61-68.
[18] Jou YC, Fang CY, Chen SY, et al. Proteomic study of renal uric acid stone[J]. Urology, 2012, 80(2): 260-266.
相似文献/References:
[1]程丹,熊承良,李洁,等.不同质量精液精浆中细胞因子IL-2、IL-6、TNF-α水平和氧化应激的关系[J].中华腔镜泌尿外科杂志(电子版),2013,(02):144.
CHENG Dan,XIONG Cheng-Liang,LI Jie,et al.Relationship of level of IL-2,IL-6,TNF-α with oxidative stress in male seminal plasma with different parameters of semen[J].,2013,(01):144.
[2]罗立旷 湛海伦 廖伟强 刘创明.糖尿病患者上尿路结石成分特点分析[J].中华腔镜泌尿外科杂志(电子版),2016,10(06):409.[doi:10.3877/cma.j.issn.1674-3253.2016.06.010
]
Luo Likuang,Zhan Hailun,Liao Weiqiang,et al.Characteristics of urinary tract stones in patients with diabetes[J].,2016,10(01):409.[doi:10.3877/cma.j.issn.1674-3253.2016.06.010
]